Palatin Technologies
PTN
#10723
Rank
โ‚ฌ11.85 M
Marketcap
6,66ย โ‚ฌ
Share price
-1.41%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -โ‚ฌ5.33 Million

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚ฌ12.88 Million. In 2025 the company made an earning of -โ‚ฌ8.33 Million, an increase over its 2024 earnings that were of -โ‚ฌ23.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ5.33 Million-36.09%
2025 -โ‚ฌ8.33 Million-64.29%
2024 -โ‚ฌ23.32 Million-16.9%
2023 -โ‚ฌ28.06 Million5.99%
2022 -โ‚ฌ26.48 Million-13.7%
2021 -โ‚ฌ30.68 Million33.25%
2020 -โ‚ฌ23.02 Million-172.11%
2019 โ‚ฌ31.92 M2352.33%
2018 โ‚ฌ1.3 M-94.13%
2017 โ‚ฌ22.18 M-154.92%
2016 -โ‚ฌ40.39 Million3.67%
2015 -โ‚ฌ38.96 Million878%
2014 -โ‚ฌ3.99 Million-72.64%
2013 -โ‚ฌ14.56 Million-33.11%
2012 -โ‚ฌ21.77 Million77.71%
2011 -โ‚ฌ12.25 Million
2003 -โ‚ฌ20.74 Million29.93%
2002 -โ‚ฌ15.97 Million36.18%
2001 -โ‚ฌ11.73 Million
1999 -โ‚ฌ9.73 Million6.04%
1998 -โ‚ฌ9.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.48 B-416,306.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.69 B-235,029.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ0.69 B-12,897.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚ฌ10.14 Million 87.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.16 B-3,151.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ0.11 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ0.10 B-1,958.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚ฌ25.52 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚ฌ50.15 Million 828.28%๐Ÿ‡บ๐Ÿ‡ธ USA